期刊文献+

中药复方双秦眼用凝胶体外释药性能 被引量:8

In vitro Releasing Property of Shuangqin Eye Gel
原文传递
导出
摘要 目的:研究双秦眼用凝胶体外释放特性。方法:以秦皮甲素为指标,采用高效液相法进行含量测定;采用改良的Franz扩散池法,以半透膜为释放膜,研究双秦眼用凝胶的体外释放特性。结果:双秦眼用凝胶中秦皮甲素的释放以一级模型拟合较好,拟合方程Y=-1.258 8 X-0.816 2(r=0.999 2)。结论:双秦眼用凝胶释放为非Fick扩散。 Objective:To study on in vivo releasing characteristics of Shuangqin eye gel.Method: The content of aesculin was determined by HPLC,which was used as index;Modified Franz diffusion cell method was applied to investigate in vitro release characteristics of Shuangqin eye gel with semi-permeable membrane as a barrier.Result: Aesculin in Shuangqin eye gel released fitted well with first order model,fitting equation of it:Y=-1.258 8 X-0.816 2(r=0.999 2).Conclusion: Release of Shuangqin eye gel was non-Fick diffusion.
出处 《中国实验方剂学杂志》 CAS 北大核心 2012年第8期9-11,共3页 Chinese Journal of Experimental Traditional Medical Formulae
基金 重大新药创制科技专项(20092X09301-005)
关键词 双秦眼用凝胶 释药性能 高效液相色谱法 FRANZ扩散池 秦皮甲素 Shuangqin eye gel releasa performance HPLC Franz diffusion cell aesculin
  • 相关文献

参考文献5

二级参考文献45

  • 1张卫,钟华玉,唐瑞嫦,钟银送,杨彩群.氟啶酸眼用缓释凝胶的制备及释药研究[J].广东药学,2005,15(4):28-30. 被引量:13
  • 2吴伟 陆彬.脂质体眼部给药系统的研究进展[EB/OL].http://www.stcsm.gov.cn.,. 被引量:1
  • 3Lang JC. Ocular drug delivery conventional ocular formulations[J]. Adv Drug Delivery Rev, 1995, 16(1) : 39-43. 被引量:1
  • 4Felt O, Baeyens V, Zignani M, et al. Mucosal drug delivery: ocular. Encyclopedia of controlled drug delivery[ M ]. Vol. 2. New York : John Wiley and Sons, 1999. 605 - 626. 被引量:1
  • 5Gangrade NK, Gaddipati NB, Ganesam MG, et al. Ocular therapeutics and drug delivery. Inl Reddy IK [ M ]. Lanchester : Technomic Publishing, 1996. 377-403. 被引量:1
  • 6Ludwig A, Van Ooteghem M. The evaluation of viscous ophthalmic vehicles by slit lamp fluorophotometry in humans[ J]. fat J Pharm, 1989, 54(2) : 95-102. 被引量:1
  • 7Ebrahim S, Peyman GA, Lee PJ. Applications of liposomes in ophthalmology [J]. Surg. Ophthalmol. , 2005, 50(2) : 167-182. 被引量:1
  • 8Irache JM, Merodio M, Arnedo A, et al. Albumin nanoparticles for the intravitreal delivery of anficytomegaloviral drugs[ J ]. Mini Rev Med Chem, 2005, 5 (3) : 293-305. 被引量:1
  • 9Bourges JL, Bloquel C, Thomas A, etal. Intraocular implants for extended drug delivery: therapeutic applications[ J ],Adv Drug Deliv Rev, 2006, 58 (11) : 1182-1202. 被引量:1
  • 10Hui HW, Robinson JR. Ocular delivery of progesterone using a bioadhesive polymer[J]. Int J Pharm, 1985, 26(3) :203-213. 被引量:1

共引文献25

同被引文献91

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部